[1]
Shivgunde, P.P., Joshi, S.R. and Kodilkar, A.D. 2019. The observational, cross-sectional study of drug utilization 90% and use of dipeptidyl peptidase-4 inhibitor in the patients with type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology. 8, 11 (Oct. 2019), 2376–2382. DOI:https://doi.org/10.18203/2319-2003.ijbcp20194771.